TITLE

Evaluating an intervention to reduce fear of falling and associated activity restriction in elderly persons: design of a randomised controlled trial [ISRCTN43792817]

AUTHOR(S)
Zijlstra, G. A. R.; van Haastregt, J. C. M.; van Eijk, J. Th. M.; Kempen, G. I. J. M.
PUB. DATE
January 2005
SOURCE
BMC Public Health;2005, Vol. 5 Issue 1, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Fear of falling and associated activity restriction is common in older persons living in the community. Adverse consequences of fear of falling and associated activity restriction, like functional decline and falls, may have a major impact on physical, mental and social functioning of these persons. This paper presents the design of a trial evaluating a cognitive behavioural group intervention to reduce fear of falling and associated activity restriction in older persons living in the community. Methods/design: A two-group randomised controlled trial was developed to evaluate the intervention. Persons 70 years of age or over and still living in the community were eligible for study if they experienced at least some fear of falling and associated activity restriction. A random community sample of elderly people was screened for eligibility; those eligible for study were measured at baseline and were subsequently allocated to the intervention or control group. Follow-up measurements were carried out directly after the intervention period, and then at six months and 12 months after the intervention. People allocated to the intervention group were invited to participate in eight weekly sessions of two hours each and a booster session. This booster session was conducted before the follow-up measurement at six months after the intervention. People allocated to the control group received no intervention as a result of this trial. Both an effect evaluation and a process evaluation were performed. The primary outcome measures of the effect evaluation are fear of falling, avoidance of activity due to fear of falling, and daily activity. The secondary outcome measures are perceived general health, self-rated life satisfaction, activities of daily life, feelings of anxiety, symptoms of depression, social support interactions, feelings of loneliness, falls, perceived consequences of falling, and perceived risk of falling. The outcomes of the process evaluation comprise the performance of the intervention according to protocol, the attendance and adherence of participants, and the participants' and facilitators' opinion about the intervention. Data of the effect evaluation will be analysed according the intention-to-treat and on-treatment principle. Data of the process evaluation will be analysed using descriptive techniques.
ACCESSION #
29361788

 

Related Articles

  • Clinical trials subjects do better than regular patients.  // Applied Clinical Trials;Aug2002, Vol. 11 Issue 8, p16 

    Compares the outcomes of clinical trial subjects and regular patients who do not participate in clinical trials. Impact of participation on progress in medical research; Initiatives to increase number of subjects participating in trials.

  • Transparency rules lead to fall in positive trial results.  // BMJ: British Medical Journal;8/15/2015, Vol. 351 Issue 8021, ph4304 

    The article discusses the study on results from trials funded by U.S. National Heart, Lung, and Blood Institute (NHLBI) in "PLoS One" journal, that found fewer large clinical trials reporting positive findings since measures designed to improve transparency were introduced.

  • Measuring patients' views: the optimum outcome measure. Ware, John E. // BMJ: British Medical Journal (International Edition);5/29/93, Vol. 306 Issue 6890, p1429 

    Focuses on the need to measure medical outcomes. Standardization of self reported measures of functioning and well being; Risk of loss precision and comprehensiveness; Debate over the choice between disease specific and generic measures of outcome in clinical trials and studies of cost...

  • YaÅŸlılarda Görülen D Vitamini EksikliÄŸinde Alfakalsidol Tedavisinin Düşme ve Denge Ãœzerine Etkileri. KAYA, Ümran; SAYGI, Evrim KARADAĞ; AKYÜZ, Gülseren // Turkish Journal of Physical Medicine & Rehabilitation / Turkiye ;jun2011, Vol. 57 Issue 2, p89 

    Objective: The aim of the present study was to investigate the impact of vitamin D treatment on balance and falls in elderly patients with vitamin D deficiency. Materials and Methods: This study was carried out in 63 women older than 65 years of age with determined vitamin D deficiency (<50...

  • Effect of Pilates training on some psychological and social factors related to falling in elderly women. Mokhtari M; Bahram ME; Pourvaghar MJ; Akasheh G // Feyz Journal of Kashan University of Medical Sciences;2013, Vol. 17 Issue 5, p453 

    Background: Falling is a common serious medical condition that affects the health of elderly persons and increases the health care costs. It also can lead to physical, psychological, social, and economic outcomes and even death. Therefore, the present study aimed to examine the effect of Pilates...

  • Long-term effect on mortality of a multicomponent cognitive behavioural group intervention to reduce fear of falling in older adults: a randomised controlled trial. Kempen, G. I. J. M.; Oude Wesselink, S. F.; van Haastregt, J. C. M.; Zijlstra, G. A. R. // Age & Ageing;Jul2011, Vol. 40 Issue 4, p519 

    A letter to the editor is presented on a study regarding the long-term mortality effect of a multicomponent cognitive behavioural group intervention to reduce fear of falling and activity avoidance in community-living older persons.

  • Interpreting Health-Related Quality-of-Life Outcomes. Kline Leidy, Nancy // Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p26 

    Focuses on the interpretation of health-related quality of life (HRQL) effects of clinical trials in the United States. Impact of clinical intervention on the patient's well-being and HRQL; Advantage of the minimal clinically important difference threshold approach; Importance of the...

  • Trial Scorecards.  // Cardiology Today;Jan2012, Vol. 15 Issue 1, p5 

    An overview of trial results in the field of cardiology is presented including one on the outcomes of a pharmacist-led intervention in patients with heart failure, one on a comparison of treatments in patients with aortoiliac peripheral artery disease and another on second-generation zotarolimus...

  • Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Ashizawa, Tetsuo; Figueroa, Karla P.; Perlman, Susan L.; Gomez, Christopher M.; Wilmot, George R.; Schmahmann, Jeremy D.; Ying, Sarah H.; Zesiewicz, Theresa A.; Paulson, Henry L.; Shakkottai, Vikram G.; Bushara, Khalaf O.; Kuo, Sheng-Han; Geschwind, Michael D.; Xia, Guangbin; Mazzoni, Pietro; Krischer, Jeffrey P.; Cuthbertson, David; Holbert, Amy Roberts; Ferguson, John H.; Pulst, Stefan M. // Orphanet Journal of Rare Diseases;2013, Vol. 8 Issue 1, p1 

    Background All spinocerebellar ataxias (SCAs) are rare diseases. SCA1, 2, 3 and 6 are the four most common SCAs, all caused by expanded polyglutamine-coding CAG repeats. Their pathomechanisms are becoming increasingly clear and well-designed clinical trials will be needed. Methods To...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics